Alkermes (ALKS) Gross Profit (2010 - 2026)
Alkermes' (ALKS) quarterly Gross Profit came in at $397.9 million in Q2 2026, up 16.62% year-over-year from $341.2 million in Q2 2025, and up 20.09% quarter-over-quarter from $331.3 million in Q1 2026.
Analysis
Alkermes (ALKS) Gross Profit (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Gross Profit for 17 consecutive years, with $397.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Profit rose 16.62% year-over-year to $397.9 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 10.05% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 2.5% from the prior year.
- Gross Profit was $397.9 million for Q2 2026 at Alkermes, up from $331.3 million in the prior quarter.
- Over five years, Gross Profit peaked at $554.1 million in Q2 2023 and troughed at $201.7 million in Q3 2022.
- A 5-year average of $312.5 million and a median of $317.2 million in 2023 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit jumped 154.36% in 2023 and plunged 39.07% in 2024, its largest moves.
- Over 5 years, Gross Profit stood at $250.8 million in 2022, then rose by 22.57% to $307.3 million in 2023, then grew by 19.69% to $367.9 million in 2024, then declined by 8.03% to $338.3 million in 2025, then gained by 17.6% to $397.9 million in 2026.
- The last three Gross Profit figures came in at $397.9 million (Q2 2026), $331.3 million (Q1 2026), and $338.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.84 Bn | 623.08 Bn | 17.26 Bn |
| 2 | AbbVie | 441.33 Bn | 434.76 Bn | 12.70 Bn |
| 3 | Merck | 364.84 Bn | 357.70 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.34 Bn | 258.65 Bn | 11.24 Bn |
| 5 | Pfizer | 159.07 Bn | 147.37 Bn | 10.94 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.22 Bn | 44.22 Bn | - |
| 8 | Incyte | 25.24 Bn | 20.70 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.42 Bn | 18.76 Bn | 683.80 Mn |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 397.90 Mn |
| Mar 31, 2026 | 331.33 Mn |
| Dec 31, 2025 | 338.34 Mn |
| Sep 30, 2025 | 342.59 Mn |
| Jun 30, 2025 | 341.20 Mn |
| Mar 31, 2025 | 257.31 Mn |
| Dec 31, 2024 | 367.87 Mn |
| Sep 30, 2024 | 315.04 Mn |
| Jun 30, 2024 | 337.66 Mn |
| Mar 31, 2024 | 291.73 Mn |
| Dec 31, 2023 | 307.35 Mn |
| Sep 30, 2023 | 319.44 Mn |
| Jun 30, 2023 | 554.15 Mn |
| Mar 31, 2023 | 229.43 Mn |
| Dec 31, 2022 | 250.75 Mn |
| Sep 30, 2022 | 201.73 Mn |
| Jun 30, 2022 | 217.86 Mn |
| Mar 31, 2022 | 223.39 Mn |
| Dec 31, 2021 | 270.85 Mn |
| Sep 30, 2021 | 244.58 Mn |